- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Supratentorial region.
Displaying page 1 of 1.
EudraCT Number: 2014-003954-15 | Sponsor Protocol Number: BIOS-14-002 | Start Date*: 2015-05-06 |
Sponsor Name:Ethicon, Inc. | ||
Full Title: A single blinded, randomized, controlled study to evaluate the safety and effectiveness of EVICELĀ® Fibrin sealant (Human) compared to a Hydrogel sealant as an adjunct to sutured dural repair | ||
Medical condition: Cerebrospinal fluid leakage in posterior fossa or supratentorial procedures (craniectomy or craniotomy) during neurosurgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016501-41 | Sponsor Protocol Number: 400-09-001 | Start Date*: 2010-06-29 |
Sponsor Name:Omrix Biopharmaceuticals Ltd | ||
Full Title: A Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Evicel as an Adjunct to Sutured Dural Repair | ||
Medical condition: tissue adhesion/sealing and suture support in neurosurgery and surgical procedures where contact with cerebrospinal fluid or dura mater can occur e.g. otologic, rhinologic, ophthalmic and vertebral... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) NL (Completed) FI (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003558-26 | Sponsor Protocol Number: BIOS-13-006 | Start Date*: 2014-07-21 |
Sponsor Name:Ethicon Inc | ||
Full Title: A Prospective, Randomized, Controlled, Study Evaluating the Safety and Efficacy of EVICELĀ® used for Suture-line sealing in Dura-Mater Closure during Paediatric Neurosurgical Cranial Procedures | ||
Medical condition: Subjects undergoing neurosurgical cranial procedures, requiring water-tight closures (suture-line sealing) in dura-mater during the surgery | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2016-003841-27 | Sponsor Protocol Number: MDNA-55-05 | Start Date*: 2017-07-19 | |||||||||||
Sponsor Name:Medicenna Therapeutics Inc. | |||||||||||||
Full Title: An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults with Recurrent or Progressive Glioblastoma | |||||||||||||
Medical condition: Glioblastoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
